大剂量辛伐他汀导致大鼠骨骼肌形态学的改变
skeletal muscle morphological changes of rat due to high-dose simvastatin
他汀类药物因其有效降低胆固醇的作用成为目前临床上应用最广泛的降脂药,但他汀类药物相关临床不良反应报告在逐渐增多,其中以肌病(1%-10%)及致死性横纹肌溶解症(0.1%)报道最为严重,且无有效预防手段,并且运动能增加他汀药物相关性肌病的发病风险。目前他汀类药物导致肌细胞坏死的机制尚不明确,他汀药物抑制甲羟戊酸途径的同时,抑制线粒体内膜辅酶Q10合成,可导致线粒体氧化呼吸功能障碍、自由基生成增加和线粒体内源途径凋亡,引起肌肉损伤。本文采用高脂血症大鼠模型,探讨大剂量辛伐他汀对大鼠骨骼肌形态学影响,结果表明只有超大剂量(约为人正常剂量30倍)辛伐他汀才会导致显著的骨骼肌损伤,提示正常剂量他汀对骨骼肌相对较安全,并且讨论了外源联合补充电子传递体CoQ10确实改善他汀药物的肌毒性,为研究他汀相关肌病的机制以及改善他汀药物相关肌病奠定基础。
Statins are the most popular lipid-lowering drug due to its effect on cholesterol control. But clinical reports on its adverse effects are gradually increasing, including statin-associated myopathy (1%-10%) and rhabdomyolysis (0.1%), and no effective prevention can be adopted. Some studies also show that exercise can increase the risk of statin-associated myopathy. Until now, the mechanism underlying statin-associated myopathy is unknown. Statins inhibit mevalonate pathway could lead to the inhibition of coenzyme Q10 synthesis on mitochondrial inner membrane, which may cause mitochondrial oxidative respiratory dysfunction, free radical increase and mitochondrial apoptosis pathway up-regulation. In this study we use hyperlipidemia rat model to investigate the skeletal muscle morphological changes due to high-dose simvastatin.The study on statin-associated myopathy could contribute to the development of prevention drugs.
温冰
基础医学药学
辛伐他汀骨骼肌辅酶Q10肌纤维坏死
simvastatinskeletal muscleCoQ10muscle fiber necrosis
温冰.大剂量辛伐他汀导致大鼠骨骼肌形态学的改变[EB/OL].(2017-05-05)[2025-08-25].http://www.paper.edu.cn/releasepaper/content/201705-480.点此复制
评论